2358 related articles for article (PubMed ID: 7962038)
1. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
[TBL] [Abstract][Full Text] [Related]
3. The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma.
Palomares T; Bilbao P; Alonso-Varona A; Barberá-Guillem E
Cancer Immunol Immunother; 1995 May; 40(5):292-8. PubMed ID: 7600560
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts.
Ishiguro H; Kishimoto T; Furuya M; Nagai Y; Watanabe T; Ishikura H
Cancer Immunol Immunother; 2005 Dec; 54(12):1191-9. PubMed ID: 15846489
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenicity of interleukin-2 (IL-2)-cDNA-transfected L1210 lymphoma and its in vivo variants is modulated by changes in IL-2 expression; potential therapeutic implications.
Chakravarty PK; Fuji H; Abu-Hadid MM; Hsu SC; Sood AK
Cancer Immunol Immunother; 1992; 35(5):347-54. PubMed ID: 1394339
[TBL] [Abstract][Full Text] [Related]
6. The National Cancer Data Base report on cancer of the vagina.
Creasman WT; Phillips JL; Menck HR
Cancer; 1998 Sep; 83(5):1033-40. PubMed ID: 9731908
[TBL] [Abstract][Full Text] [Related]
7. Labial melanotic macule: a clinical, histopathologic, and ultrastructural study.
Ho KK; Dervan P; O'Loughlin S; Powell FC
J Am Acad Dermatol; 1993 Jan; 28(1):33-9. PubMed ID: 8425968
[TBL] [Abstract][Full Text] [Related]
8. The use of biomarkers to study pathogenesis and mechanisms of cancer: oesophagus and skin cancer as models.
Montesano R; Hainaut P; Hall J
IARC Sci Publ; 1997; (142):291-301. PubMed ID: 9354928
[TBL] [Abstract][Full Text] [Related]
9. Nodular balloon cell component in a cutaneous melanoma of the superficial spreading type.
Kiene P; Petres-Dunsche C; Funke G; Christophers E
Dermatology; 1996; 192(3):274-6. PubMed ID: 8726648
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous regression of cancer and the importance of finding its cause.
Cole WH
Natl Cancer Inst Monogr; 1976 Nov; 44():5-9. PubMed ID: 799760
[TBL] [Abstract][Full Text] [Related]
11. Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
Sharma D; Chelvi TP; Kaur J; Ralhan R
Melanoma Res; 1998 Jun; 8(3):240-4. PubMed ID: 9664145
[TBL] [Abstract][Full Text] [Related]
12. Superficial spreading melanoma and blue naevus within naevus spilus--ultrastructural assessment of giant pigment granules.
Cox NH; Malcolm A; Long ED
Dermatology; 1997; 194(3):213-6. PubMed ID: 9187835
[TBL] [Abstract][Full Text] [Related]
13. Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessments.
Sleijfer S; van Ginkel RJ; van der Mark TW; Hoekstra HJ; Zwaveling JH; Schraffordt Koops H; Mulder NH
J Immunother; 1997 May; 20(3):202-7. PubMed ID: 9181458
[TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of human MEL-7 melanoma metastasis in nude and beige/nude mice].
Bryzgalov IP; Sorokina IuD; Solov'ev IuN; Revazova ES
Biull Eksp Biol Med; 1996 Jan; 121(1):89-90. PubMed ID: 8680015
[No Abstract] [Full Text] [Related]
16. [Therapeutic efficiency of an angiogenesis inhibitor, TNP-470, against carcinomatous peritonitis in rodents].
Ozaki K; Takahashi T; Hagiwara A; Shimotsuma M; Sakakura C; Sasaki S; Shirasu M; Tsujimoto H; Oyama T; Sakakibara T
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1575-7. PubMed ID: 8373222
[TBL] [Abstract][Full Text] [Related]
17. Effect of clinically relevant irradiation regimes on human malignant melanomas grown in athymic nude mice.
Rofstad EK; Brustad T; Johannessen JV
Acta Radiol Ther Phys Biol; 1977 Jun; 16(3):273-80. PubMed ID: 906896
[TBL] [Abstract][Full Text] [Related]
18. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.
Jäeger E; Bernhard H; Romero P; Ringhoffer M; Arand M; Karbach J; Ilsemann C; Hagedorn M; Knuth A
Int J Cancer; 1996 Apr; 66(2):162-9. PubMed ID: 8603805
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration.
Caraceni A; Martini C; Belli F; Mascheroni L; Rivoltini L; Arienti F; Cascinelli N
Eur J Cancer; 1993; 29A(9):1266-9. PubMed ID: 8343265
[TBL] [Abstract][Full Text] [Related]
20. Whole-body hyperthermia. A systemic treatment for disseminated cancer.
Pettigrew RT; Lugate CM
Recent Results Cancer Res; 1977; (59):153-70. PubMed ID: 897330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
